These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1806545)

  • 1. Lipoprotein immune complexes as markers of atherosclerosis.
    Orekhov AN; Kalenich OS; Tertov VV; Novikov ID
    Int J Tissue React; 1991; 13(5):233-6. PubMed ID: 1806545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein abnormalities and extracoronary atherosclerosis in patients with premature ischemic heart disease.
    Rubba P; Faccenda F; Iorio D; Pauciullo P; Cortese C; Spampinato N; Mancini M
    Int Angiol; 1987; 6(4):331-7. PubMed ID: 3330114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis].
    Kalenich OS; Tertov VV; Liakishev AA; Ruda MIa; Orekhov AN
    Ter Arkh; 1991; 63(9):59-61. PubMed ID: 1759226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
    Tedeschi-Reiner E; Reiner Z; Sonicki Z
    Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
    Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
    Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
    Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
    Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol and triglycerides in atherosclerosis: epidemiologic and physiopathologic considerations].
    Davidoff P
    Rev Med Chil; 1991 Sep; 119(9):1050-8. PubMed ID: 1845100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From cholesterol to lipoprotein particle markers and/or risk factors].
    Fruchart JC; Cottet J
    Bull Acad Natl Med; 1991 Jan; 175(1):51-62; discussion 62-5. PubMed ID: 1863858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interpretation of B and A apoproteins dosage in the acute accidents of the cerebral and coronary atherosclerosis. Age influence upon the results (author's transl)].
    Bugugnani MJ; Haiat R; Fouyé H; Rémy A; Desoutter P
    Ann Biol Clin (Paris); 1981; 39(3):131-4. PubMed ID: 6787958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
    Yoo WH
    J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenetic significance of cholesterol-containing immune complexes and lipid peroxidation in ischemic heart disease].
    Urazgil'deeva SA; Shatalina LV; Gurevich VS
    Ter Arkh; 1999; 71(12):8-10. PubMed ID: 10647190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of plasma apolipoprotein B in myocardial infarction in young subjects. Correlations with coronarographic data].
    Douste-Blazy P; Solera ML; Delay M; De Graeve J; Valdiguie P; Marco J; Bernadet P
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):21-6. PubMed ID: 6422890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of lipids, apoproteins and lipoproteins in patients with coronary disease and in a control population].
    Marzullo C; Michotey O; Bourderont D; Levy J; Jung S; Tissot J; Huber-Braun C; Dorr R
    Ann Biol Clin (Paris); 1994; 52(10):717-20. PubMed ID: 7747879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of plasma lipids in carotid bifurcation atherosclerosis.
    Ford CS; Crouse JR; Howard G; Toole JF; Ball MR; Frye J
    Ann Neurol; 1985 Mar; 17(3):301-3. PubMed ID: 3994317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG; Tertov VV; Orekhov AN
    Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.